<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Policy on Too Allergic</title><link>https://www.tooallergic.com/categories/policy/</link><description>Recent content in Policy on Too Allergic</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Sun, 05 Apr 2026 09:50:04 +0000</lastBuildDate><atom:link href="https://www.tooallergic.com/categories/policy/index.xml" rel="self" type="application/rss+xml"/><item><title>2026 Guide to Overcoming Allergy Care Deserts with Hybrid Models</title><link>https://www.tooallergic.com/2026-guide-to-overcoming-allergy-care-deserts-with-hybrid-models/</link><pubDate>Sun, 05 Apr 2026 09:50:04 +0000</pubDate><guid>https://www.tooallergic.com/2026-guide-to-overcoming-allergy-care-deserts-with-hybrid-models/</guid><description>&lt;h1 id="2026-guide-to-overcoming-allergy-care-deserts-with-hybrid-models"&gt;2026 Guide to Overcoming Allergy Care Deserts with Hybrid Models&lt;/h1&gt;
&lt;p&gt;Allergy care deserts—places where getting to an allergist is impractical or impossible—are widening wait times and inequities. The most effective, scalable way to close these gaps in 2026 is a hybrid allergy care model that blends telemedicine, remote monitoring, responsible AI decision support, and targeted in‑person services. This approach expands reach, lowers costs, and preserves clinical quality when programs are designed with safety and equity in mind. In short: hybrid care meets patients where they are while keeping doors open for in‑person testing and procedures. Evidence shows telehealth increases access and supports patient‑centered care, and mobile tools now capture real‑time symptoms and triggers to fine‑tune therapy between visits (see the Frontiers in Allergy 2026 review). Too Allergic is built around this hybrid approach to pair virtual care with evidence‑based, in‑person services when needed.&lt;/p&gt;</description></item></channel></rss>